Rajah Vignesh

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$204,738.06
Insider Sells Quantity
1
Insider Sells Sum
$28,282.83

Insider Activity of Rajah Vignesh

According to the SEC Form 4 filings, Rajah Vignesh, being in a position of

  1. SVP & CHIEF MEDICAL OFFICER at Y-mAbs Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1711 share for $28,283,
    over all time since 2020-11-17, has bought 5963 shares for $204,738, and sold 1711 share for $28,283.

The largest purchase of all time was on 2020-11-17 and amounted to 2928 shares of Y-mAbs Therapeutics, Inc. for $133,927.

The largest sale of all time was on 2024-03-05 and amounted to 1711 share of Y-mAbs Therapeutics, Inc. for $28,283.

Biography of Rajah Vignesh

No biography is available at this moment.

2024-03-05SaleY-mAbs Therapeutics, Inc.
YMAB
SVP & CHIEF MEDICAL OFFICER
1,711
0.0039%
$16.53$28,283-16.86%
2022-11-15PurchaseY-mAbs Therapeutics, Inc.
YMAB
SVP & CMO
1,195
0.003%
$4.92$5,884+19.11%
2021-08-12PurchaseY-mAbs Therapeutics, Inc.
YMAB
SVP & CMO
1,374
0.0031%
$29.95$41,147-47.9%
2020-12-02PurchaseY-mAbs Therapeutics, Inc.
YMAB
SVP and CMO
466
0.0012%
$51.03$23,780-35.21%
2020-11-17PurchaseY-mAbs Therapeutics, Inc.
YMAB
SVP and CMO
2,928
0.0073%
$45.74$133,927-26.42%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.